Germany
Tuberculosis profile
Population  2013 83 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.3 (0.29–0.3) 0.36 (0.36–0.37)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.01 (0–0.01)
Prevalence  (includes HIV+TB) 6.2 (2.6–11) 7.5 (3.2–14)
Incidence  (includes HIV+TB) 4.8 (4.4–5.2) 5.8 (5.3–6.3)
Incidence (HIV+TB only) 0.034 (0.031–0.083) 0.04 (0.04–0.1)
Case detection, all forms (%) 87 (81–96)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.3 (1.7–3.1) 21 (14–30)
MDR-TB cases among notified pulmonary
TB cases
73 (54–97) 49 (33–69)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 2 628   83
Pulmonary, clinically diagnosed 483   22
Extrapulmonary 947   30
       
Total new and relapse 4 193    
Previously treated, excluding relapses 125    
Total cases notified 4 318    
Among 4 177 new and relapse cases:
168 (4%) cases aged under 15 years; male:female ratio: 1.6
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 651 (25%) 118 (45%) 2 372
Laboratory-confirmed RR-/MDR-TB cases     112
Patients started on MDR-TB treatment     98
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 74
Previously treated cases, excluding relapse, registered in 2012 61
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011 53
XDR-TB cases started on second-line treatment in 2011 100
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in and outside
country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-28 Data: www.who.int/tb/data